You have 9 free searches left this month | for more free features.

Condition

Diabetes Mellitus Type 2 (2)

Obesity (2)

Non Alcoholic Fatty Liver Disease (1)

Non-alcoholic Fatty Liver Disease (1)

Oral Mucositis (1)

Overall Status

Completed (2)

Suspended (1)

Sign in for free

Phase

phase 2 (3)

Sponsor

University of Michigan (2)

Access Pharmaceuticals, Inc. (1)

Collaborator

Advanced Clinical Research Services, LLC (1)

Intervention

amlexanox (3)

placebo (1)

vehicle rinse (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

amlexanox

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Diabetes Type 2, Non Alcoholic Fatty Liver Disease, Obesity Trial in Ann Arbor (Amlexanox)

Suspended

Diabetes Mellitus Type 2
+2 more

Amlexanox

Ann Arbor, Michigan

University of Michigan

Jan 10, 2022

Diabetes Type 2, Non-alcoholic Fatty Liver Disease, Obesity Trial in Ann Arbor (Amlexanox, Placebo)

Completed

Has Results

Diabetes Mellitus Type 2
+2 more

Amlexanox
Placebo

Ann Arbor, Michigan

University of Michigan

Oct 8, 2018

Oral Mucositis Trial in United States (amlexanox, Vehicle rinse)

Completed

Oral Mucositis

amlexanox
Vehicle rinse

Mobile, Alabama
+11 more

Mar 16, 2010